Related Experiment Video
Updated: Jul 2, 2025

10:03
Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis
Published on: July 16, 2008
27.2K
Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation
Maja Juković1, Ivana Ratkaj1, Daniela Kalafatovic1
1Faculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.
Biophysical Chemistry
|February 21, 2024
Summary
This study differentiates amyloid and amorphous aggregates, crucial for understanding disease mechanisms. Peptide self-assemblies offer simplified models to investigate protein aggregation and phase separation, aiding in developing new therapeutic targets.
Area of Science:
- Biochemistry
- Biophysics
- Molecular Biology
Background:
- Amyloid and amorphous aggregates are implicated in various diseases.
- Current research often overlooks the distinct characteristics of these aggregate types.
- A clearer distinction is needed for accurate disease modeling and therapeutic development.
Purpose of the Study:
- To compare amyloid and amorphous aggregates based on biochemical properties, kinetics, and morphology.
- To utilize peptide self-assemblies as simplified models for studying protein aggregation.
- To explore liquid-liquid phase separation as a precursor to amyloid formation.
Main Methods:
- Comparative analysis of aggregate properties.
- Employing peptide self-assemblies as model systems.
- Investigating liquid-liquid phase separation mechanisms.
Main Results:
- Distinct biochemical, kinetic, and morphological features differentiate amyloid and amorphous aggregates.
- Peptide self-assemblies provide a tractable model for complex protein aggregation.
- Liquid-liquid phase separation is identified as a potential preceding event in amyloidogenesis.
Conclusions:
- Differentiating aggregate types is essential for understanding disease.
- Peptide models offer valuable insights into protein aggregation and phase separation.
- This research may lead to novel therapeutic targets for aggregation-related disorders.

